Health insurance in America is not a system built to deliver care. It is a financial intermediary — a layer of profit-taking inserted between patients and the providers who treat them. That distinction is not a rhetorical flourish. It is a structural description of what the industry actually does, how it is regulated, and what it has been optimized to produce over decades of consolidation, lobbying, and regulatory capture.
Understanding that structure is the purpose of this article. The mechanisms — how claims are denied, how prior authorization works, how benefit design discourages care, how networks are built to reduce costs rather than expand access — are covered in the articles that follow. This article establishes the architecture those mechanisms operate inside.
What Health Insurance Is — and What It Isn’t
The original rationale for insurance is straightforward: individuals pool risk so that no single person bears the full cost of a catastrophic event. The actuarial logic is sound. Applied to healthcare, it means that a large group of people pay premiums into a shared fund, and when any one of them needs expensive care, the fund pays for it.
That is not primarily how American health insurance works today.
American health insurance is dominated by four for-profit companies — UnitedHealth Group, Cigna, Elevance Health (formerly Anthem), and CVS Health, which acquired Aetna in 2018. Together, these four companies cover the majority of commercially insured Americans. They are not mutual aid societies pooling risk for the benefit of their members. They are publicly traded corporations with shareholders, quarterly earnings expectations, executive compensation tied to financial performance, and a fundamental structural obligation to generate profit.
That obligation shapes everything. An insurer that pays out more in claims than its competitors is not a better insurer — it is a less profitable one. The financial incentive runs in one direction: minimize what goes out in claims, maximize what stays in the company. Every structural feature of the insurance industry that patients find confusing, frustrating, or harmful flows from that incentive.
The Medical Loss Ratio: The Most Important Number You’ve Never Heard Of
The medical loss ratio — MLR — is the percentage of premium revenue that an insurer pays out as claims. It is the central financial mechanism of the insurance business, and it is the lens through which everything else in this hub should be read.
The Affordable Care Act, enacted in 2010, established minimum MLR requirements for the first time at the federal level. Large-group insurers — those covering employers with more than fifty employees — must spend at least 85 cents of every premium dollar on claims and quality improvement activities. Small-group and individual market insurers must spend at least 80 cents. Insurers that fall below these thresholds are required to issue rebates to policyholders.
What the law does not cap is what happens with the remaining 15 to 20 cents. Administrative costs, executive compensation, marketing, lobbying, and shareholder profit all come from that share. In practice, the largest insurers consistently operate at or near the MLR minimums — treating the regulatory floor as an operational ceiling. The retained margin is not a residual. It is the target.
To put numbers on it: in 2023, UnitedHealth Group reported net earnings of $22.4 billion. CVS Health reported operating income of $15.8 billion from its health services and insurance operations. Cigna reported adjusted income from operations of $8.3 billion. Elevance Health reported net income of $6.0 billion. These are not the margins of a thin-profit utility providing an essential service under tight regulation. They are the returns on a financial intermediary that has positioned itself at the center of American healthcare and extracts value at every transaction.
The MLR floor matters and the ACA’s establishment of it was a genuine constraint on the worst behavior. But it left the profit extraction structure intact. An insurer operating at exactly the 85 percent MLR minimum is fully compliant with federal law and is still retaining 15 cents of every premium dollar — on top of a premium base that has grown faster than wages, faster than inflation, and faster than the underlying cost of care for most of the past two decades.
The Regulatory Landscape
Health insurance in America is regulated at three levels, and understanding the interaction between them explains a great deal about why reform is difficult and why the industry’s structural position is durable.
Federal regulation covers the ACA’s minimum standards — guaranteed issue, community rating, essential health benefits, the MLR floor, and marketplace rules. It also covers Medicare and Medicaid, including Medicare Advantage, where insurers operate within a federally administered payment structure. Federal regulation sets a floor but does not set a ceiling on premiums, does not cap administrative costs above the MLR threshold, and does not regulate insurer profit directly.
State insurance commissioners regulate the commercial insurance market above the federal floor. States set their own solvency requirements, review premium rate increases in many markets, and enforce network adequacy standards. The strength of state regulation varies enormously. Some states conduct rigorous rate review with genuine authority to reject excessive increases. Others have insurance commissioners with limited staff, limited authority, or structural incentives to accommodate the industry they regulate.
ERISA preemption is the structural protection that the industry relies on most heavily and that most patients have never heard of. The Employee Retirement Income Security Act of 1974 preempts state regulation of self-insured employer health plans — plans in which the employer bears the financial risk of claims rather than purchasing a fully insured product from a carrier. Roughly two-thirds of covered workers are in self-insured plans. That means the primary mechanism of state insurance regulation — rate review, network adequacy standards, coverage mandates — does not apply to the majority of employer-sponsored coverage. ERISA preemption was not designed to protect insurers from state oversight. It was designed to allow multi-state employers to offer uniform benefits. Its effect, over fifty years, has been to create a large regulatory exemption at the center of the commercial insurance market.
Consolidation: What It Produced
The American health insurance market has consolidated dramatically over the past two decades. Mergers, acquisitions, and market exits have reduced the number of major national carriers and increased the market concentration in most regional markets.
The ACA’s minimum loss ratio requirements accelerated consolidation by reducing the margin available to smaller, less efficient carriers. The result was a wave of mergers in the years following the ACA’s implementation. Aetna and Humana announced a merger in 2015; it was blocked by the Department of Justice on antitrust grounds. Anthem and Cigna announced a merger the same year; that too was blocked. CVS Health’s acquisition of Aetna in 2018, at $69 billion, was approved and created a vertically integrated insurer-pharmacy-benefits manager-retail pharmacy conglomerate that is now one of the largest companies in the United States by revenue.
UnitedHealth Group has pursued a different consolidation strategy — acquiring physician practices, surgery centers, and health data companies through its Optum subsidiary, creating a vertically integrated structure in which UnitedHealth is both the insurer adjudicating claims and the provider receiving payment for care. The antitrust implications of that structure are the subject of active regulatory scrutiny.
What consolidation has not produced is lower premiums, better coverage, or improved patient outcomes. Average family premiums for employer-sponsored coverage increased from approximately $13,375 in 2009 to $23,968 in 2023, according to the Kaiser Family Foundation’s annual employer health benefits survey — an increase of roughly 79 percent in fourteen years, against cumulative inflation over the same period of approximately 46 percent. Consolidation reduced competitive pressure on pricing without producing the efficiency gains that consolidation proponents projected.
Who the System Is Built For
The organized interests that benefit from the current structure maintain sustained institutional presence in Washington and in every state capital. The major health insurers are among the largest lobbying spenders in American healthcare. America’s Health Insurance Plans — the industry’s primary trade association — spent $27.8 million on lobbying in 2023, according to OpenSecrets. Individual carrier lobbying expenditures add to that total: UnitedHealth Group spent $8.9 million, Cigna spent $7.2 million, Elevance Health spent $5.9 million.
These figures do not include campaign contributions, state-level lobbying, or the revolving door of staff movement between the insurance industry and the regulatory agencies that oversee it. They represent the declared, public-facing portion of the industry’s political investment.
The result is a regulatory environment that has consistently accommodated the industry’s core financial interests while producing genuine but limited consumer protections. The ACA established minimum standards that matter. It did not restructure the industry’s relationship to profit. The MLR floor is real. The premium growth above it is also real. Both things are true simultaneously, and the gap between them is where the industry’s structural advantage lives.
This is not an argument about the character of insurance executives or the motives of lobbyists. It is an argument about structure. An industry that is required by law to pay 80 to 85 cents of premium revenue in claims, and that faces no binding constraint on the premium base itself, has a structural incentive to grow that premium base as fast as market and regulatory conditions allow. That is what it has done.
What the Rest of This Hub Documents
The articles that follow examine the specific mechanisms through which the insurance industry’s financial architecture produces its documented outcomes — for patients, for providers, and for the healthcare system as a whole.
The money: How insurers make their profit, how benefit design is engineered to reduce claims, and what executive compensation and shareholder returns look like when the numbers are made concrete.
The mechanisms of denial: The denial system and how it is structured, the prior authorization process and what patients experience, and the administrative burden those systems impose on providers and the healthcare system.
The market structures: How networks are built and what adequacy standards fail to deliver, why employer-sponsored insurance traps workers and distorts the labor market, and what the broker and consultant layer adds to the cost and the conflict of interest.
Medicare Advantage: How the privatized Medicare program uses the risk-adjustment payment structure to generate overpayments documented by federal auditors, and what the enforcement record looks like.
The insurance industry is one mechanism in a larger system. Hospital consolidation, pharmaceutical pricing, and pharmacy benefit manager practices all interact with insurance structures to produce the outcomes patients experience. Where those connections matter, articles in this hub cross-link to the Hospital Consolidation and Market Power hub, the Prescription Drug Pricing hub, and the Medicare Advantage and Private Medicare hub.
Health Insurance Hub
00 — Hub: Health Insurance Industry
01 — How the Health Insurance Industry Works — and Who It Works For
02 — How Health Insurers Make Money
03 — Designed to Discourage: How Benefit Structures Reduce Claims
04 — The Denial System: How Insurers Decide What Not to Pay
05 — Prior Authorization: What Patients Experience
06 — The Administrative Burden and What It Costs
07 — Narrow Networks and What They Cost You
08 — The Employer-Sponsored Insurance Trap
09 — The Broker and Consultant Layer
10 — Billed for Diseases They Never Treated: How Medicare Advantage Fraud Works
11 — What Single-Payer Resolves: The Evidence From This Hub
12 — Health Care Forum: Join the conversation here
This article was researched and drafted with AI assistance under human review. See our full AI and editorial practices.